Yemaachi, a Ghanaian cancer diagnostics and research company completes $3 million in a seed round
Yemaachi Biotech, a Ghanaian cancer research and diagnostics company, has raised $3 million in a seed round to advance its goal of global precision oncology diversification. V8 Capital led the round, which included LifeLine Family Heritage Fund, Y Combinator, Tencent, LoftyInc Capital, VestedWorld, V Square Capital, and Ethan Perlstein. In January, the company launched its…